Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.49 |
| ▸ | THRB | P10828 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | RECQL | P46063 | 3/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.49 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.49 |
| ▸ | BLM | P54132 | 2/20 | 0.49 |
| ▸ | APEX1 | P27695 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.49 |
| ▸ | MPL | P40238 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29460983 | 1.00 | KMT2A (0.49) | KMT2AMAPK1ALDH1A1MAPTKDM4E | |
| SCHEMBL29351257 | 1.00 | KMT2A (0.49) | KMT2AMAPK1ALDH1A1MAPTKDM4E | |
| SCHEMBL593620 | 0.98 | KMT2A (0.48) | KMT2AMAPK1ALDH1A1MAPTKDM4E | |
| SCHEMBL593622 | 0.98 | KMT2A (0.48) | KMT2AMAPK1ALDH1A1MAPTKDM4E | |
| SCHEMBL15849895 | 0.88 | ALDH1A1 (0.44) | KMT2AMAPK1ALDH1A1MAPTKDM4E | |
| SCHEMBL305044 | 0.82 | CYP1A2 (0.44) | KMT2AMAPK1ALDH1A1MAPTKDM4E | |
| SCHEMBL29440271 | 0.82 | KDM4E (0.38) | KMT2AMAPK1ALDH1A1MAPTKDM4E | |
| SCHEMBL22125496 | 0.82 | KDM4E (0.38) | KMT2AMAPK1ALDH1A1MAPTKDM4E | |
| SCHEMBL29440272 | 0.82 | KDM4E (0.38) | KMT2AMAPK1ALDH1A1MAPTKDM4E | |
| SCHEMBL10076070 | 0.81 | HSD17B10 (0.42) | KMT2AMAPK1ALDH1A1MAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011068944-A1 | TETRAIONIC LIQUID SALTS AND METHODS OF USE THEREOF | SIGMA-ALDRICH CO. (US) | 2011-06-09 | — | — | WO | claimed |
| WO-1994009773-A1 | NEW ANTIVIRAL AGENTS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1994-05-11 | — | — | WO | claimed |
| US-12626364-B2 | Materials and methods related to image processing | ADVANCED CELL DIAGNOSTICS, INC. (US) | 2026-05-12 | — | — | US | disclosed |
| US-20260110019-A1 | METHODS FOR MULTIPLEX DETECTION OF NUCLEIC ACIDS BY IN SITU HYBRIDIZATION | ADVANCED CELL DIAGNOSTICS, INC. | 2026-04-23 | — | — | US | disclosed |
| US-20260078430-A1 | METHODS FOR DETECTING TARGET NUCLEIC ACIDS USING RNA BLOCKING MOLECULES | ADVANCED CELL DIAGNOSTICS INC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260079162-A1 | SYSTEMS, METHODS, AND KITS FOR DETECTING PROTEIN INTERACTIONS | ADVANCED CELL DIAGNOSTICS INC (US) | 2026-03-19 | — | — | US | disclosed |
| US-12577610-B2 | Methods for detecting target nucleic acids by in situ hybridization and a kit thereof | ADVANCED CELL DIAGNOSTICS, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| US-12571028-B2 | Methods for multiplex detection of nucleic acids by in situ hybridization | ADVANCED CELL DIAGNOSTICS, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| US-12465637-B2 | Compositions and methods for modulation of antibody activity | INSTITUTE FOR CANCER RESEARCH (US) | 2025-11-11 | — | — | US | disclosed |
| US-20250230491-A1 | IN SITU DETECTION OF NUCLEOTIDE VARIANTS IN HIGH NOISE SAMPLES, AND COMPOSITIONS AND METHODS RELATED THERETO | ADVANCED CELL DIAGNOSTICS, INC. | 2025-07-17 | — | — | US | disclosed |
| US-20250179196-A1 | MATERIALS AND METHODS OF MAKING OR USING IL-23R BINDING PROTEINS | JANSSEN BIOTECH INC (US) | 2025-06-05 | — | — | US | disclosed |
| CN-1375059-A | Fluorescent compounds for use in industrial water systems | NALCO CHEMICAL CO (US) | 2002-10-16 | — | — | CN | disclosed |
| EP-1228376-A1 | FLUORESCENT COMPOUNDS FOR USE IN INDUSTRIAL WATER SYSTEMS | NALCO CHEMICAL COMPANY (US) | 2002-08-07 | — | — | EP | disclosed |
| US-6358746-B1 | SIGNAL EMITTING MARKER FOR USE IN MONITORING WASTE | NALCO CHEMICAL COMPANY | 2002-03-19 | — | — | US | disclosed |
| WO-2001035107-A1 | FLUORESCENT COMPOUNDS FOR USE IN INDUSTRIAL WATER SYSTEMS | NALCO CHEMICAL COMPANY (US) | 2001-05-17 | — | — | WO | disclosed |
| US-6180356-B1 | Membrane pore inhibiting agents for treating infection | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NY | 2001-01-30 | — | — | US | disclosed |
| WO-1999045391-A1 | MEMBRANE PORE INHIBITING AGENTS FOR TREATING INFECTION | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1999-09-10 | — | — | WO | disclosed |
| EP-0278149-B1 | INDIRECT COLORIMETRIC DETECTION OF AN ANALYTE IN A SAMPLE USING RATIO OF LIGHT SIGNALS | Becton, Dickinson and Company (US) | 1992-09-09 | — | — | EP | disclosed |
| US-4954435-A | Indirect colorimetric detection of an analyte in a sample using ratio of light signals | BECTON, DICKINSON AND COMPANY (US) | 1990-09-04 | — | — | US | disclosed |
| EP-0278149-A2 | Indirect colorimetric detection of an analyte in a sample using ratio of light signals | Becton, Dickinson and Company (US) | 1988-08-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260110019-A1 | METHODS FOR MULTIPLEX DETECTION OF NUCLEIC ACIDS BY IN SITU HYBRIDIZATION | CPSF6, CPSF1, LMNA | KMT2A 3011/4885MAPK1 3894/4885ALDH1A1 3057/4885 |
| US-12571028-B2 | Methods for multiplex detection of nucleic acids by in situ hybridization | ADAR, CPSF6, LMNA | KMT2A 1813/4885MAPK1 4238/4885ALDH1A1 2293/4885 |
| US-12577610-B2 | Methods for detecting target nucleic acids by in situ hybridization and a kit thereof | AGO2, STAU1, SNRPF | KMT2A 715/4885MAPK1 2870/4885ALDH1A1 685/4885 |
| US-12465637-B2 | Compositions and methods for modulation of antibody activity | FCGR3B, FCGR2A, FCGRT | KMT2A 3135/4885MAPK1 4398/4885ALDH1A1 4212/4885 |
| US-20260078430-A1 | METHODS FOR DETECTING TARGET NUCLEIC ACIDS USING RNA BLOCKING MOLECULES | AGO2, SLIRP, SYNCRIP | KMT2A 1100/4885MAPK1 2814/4885ALDH1A1 2579/4885 |
| US-20260079162-A1 | SYSTEMS, METHODS, AND KITS FOR DETECTING PROTEIN INTERACTIONS | CD2BP2, CD68, IGLV6-57 | KMT2A 944/4885MAPK1 4696/4885ALDH1A1 4116/4885 |
| US-12626364-B2 | Materials and methods related to image processing | HNRNPF, HNRNPD, HNRNPDL | KMT2A 3095/4885MAPK1 3068/4885ALDH1A1 1998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.